Study examines outcomes associated with anaemia management for patients with end-stage renal disease
Friday, March 19, 2010 - 09:43
in Health & Medicine
Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower haematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for haemodialysis patients, according to a study in the March 3 issue of JAMA...